Skip to main content
MedWatcherBeta

Loading research and source information…

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis for Multiple sclerosis: evidence and status · MedWatcher